| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |